{"id":"https://openalex.org/W2423966313","doi":null,"title":"Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.","display_name":"Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.","publication_year":2015,"publication_date":"2015-07-01","ids":{"openalex":"https://openalex.org/W2423966313","mag":"2423966313","pmid":"https://pubmed.ncbi.nlm.nih.gov/26120779"},"language":"en","primary_location":{"id":"pmid:26120779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26120779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental rheumatology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089079996","display_name":"C. Chapelon-Abric","orcid":"https://orcid.org/0000-0002-2821-6626","observed_orcids":["https://orcid.org/0000-0002-2821-6626"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Catherine Chapelon-Abric","raw_affiliation_strings":["1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210121705","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085912537","display_name":"David Saadoun","orcid":"https://orcid.org/0000-0003-3628-9996","observed_orcids":["https://orcid.org/0000-0003-3628-9996"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"David Saadoun","raw_affiliation_strings":["1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210121705","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037713107","display_name":"Lucie Biard","orcid":"https://orcid.org/0000-0003-0660-1264","observed_orcids":["https://orcid.org/0000-0003-0660-1264"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lucie Biard","raw_affiliation_strings":["Department of Biostatistics and Medical Information (SBIM), H\u00f4pital Saint Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Medical Information (SBIM), H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002774188","display_name":"D. S\u00e8ne","orcid":"https://orcid.org/0000-0001-8640-4580","observed_orcids":["https://orcid.org/0000-0001-8640-4580"]},"institutions":[{"id":"https://openalex.org/I4210119095","display_name":"H\u00f4pital Lariboisi\u00e8re","ror":"https://ror.org/02mqtne57","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210119095"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Damien Sene","raw_affiliation_strings":["Service de M\u00e9decine Interne, H\u00f4pital Lariboisi\u00e8re, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de M\u00e9decine Interne, H\u00f4pital Lariboisi\u00e8re, Paris, France","institution_ids":["https://openalex.org/I4210119095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026054699","display_name":"Matthieu Resche\u2010Rigon","orcid":"https://orcid.org/0000-0003-2220-5085","observed_orcids":["https://orcid.org/0000-0003-2220-5085"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Matthieu Resche-Rigon","raw_affiliation_strings":["Department of Biostatistics and Medical Information (SBIM), H\u00f4pital Saint Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Medical Information (SBIM), H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000662815","display_name":"B. Hervier","orcid":"https://orcid.org/0000-0002-1388-1121","observed_orcids":["https://orcid.org/0000-0002-1388-1121"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Baptiste Hervier","raw_affiliation_strings":["1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210121705","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062315921","display_name":"Nathalie Costedoat-Chalumeau","orcid":"https://orcid.org/0000-0002-1555-9021","observed_orcids":["https://orcid.org/0000-0002-1555-9021","https://orcid.org/0000-0001-6031-574X"]},"institutions":[{"id":"https://openalex.org/I4210092774","display_name":"H\u00f4pital Cochin","ror":"https://ror.org/00ph8tk69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Costedoat-Chalumeau","raw_affiliation_strings":["Service de M\u00e9decine Interne, H\u00f4pital Cochin, Universit\u00e9 Ren\u00e9 Descartes, Centre de R\u00e9f\u00e9rence Maladies Auto-immunes et Syst\u00e9miques Rares, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de M\u00e9decine Interne, H\u00f4pital Cochin, Universit\u00e9 Ren\u00e9 Descartes, Centre de R\u00e9f\u00e9rence Maladies Auto-immunes et Syst\u00e9miques Rares, Paris, France","institution_ids":["https://openalex.org/I4210092774","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080872703","display_name":"Aur\u00e9lie Drier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurelie Drier","raw_affiliation_strings":["D\u00e9partement de Neuroradiologie, Universit\u00e9 Pierre et Marie Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Neuroradiologie, Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108435398","display_name":"Jean Marc Leger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Marc Leger","raw_affiliation_strings":["D\u00e9partement de Neurologie, Universit\u00e9 Pierre et Marie Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Neurologie, Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I4405264447"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037078532","display_name":"P. Cacoub","orcid":"https://orcid.org/0000-0002-6727-4992","observed_orcids":["https://orcid.org/0000-0002-6727-4992"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrice Cacoub","raw_affiliation_strings":["1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1.Sorbonne Universit\u00e9s, UPMC Univ Paris, UMR7211 & Inflammation-Immunopathology-Biotherapy Dept. (DHU i2B); 2.INSERM, UMR_S959, Paris; 3.CNRS, FRE3632, Paris; 4.APHP, Groupe Hosp. Piti\u00e9 Salp\u00e9tri\u00e8re, Dept. Internal Medicine & Clin.Immunol, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210121705","https://openalex.org/I4405264447"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0243,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.92007831,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"33","issue":"4","first_page":"509","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/refractory-sarcoidosis","display_name":"refractory sarcoidosis","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cardiac-sarcoidosis","display_name":"cardiac sarcoidosis","score":0.7960000038146973},{"id":"https://openalex.org/keywords/central-nervous-system-sarcoidosis","display_name":"central nervous system sarcoidosis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/steroid-sparing-effect","display_name":"steroid-sparing effect","score":0.734000027179718},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6470000147819519},{"id":"https://openalex.org/keywords/infectious-complications","display_name":"infectious complications","score":0.9079999923706055},{"id":"https://openalex.org/keywords/leukoencephalopathy","display_name":"leukoencephalopathy","score":0.9750000238418579},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9746284484863281},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8666724562644958},{"id":"https://openalex.org/C2781301800","wikidata":"https://www.wikidata.org/wiki/Q193894","display_name":"Sarcoidosis","level":2,"score":0.8296284675598145},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.728844404220581},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6325832009315491},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5057330131530762},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.504621148109436},{"id":"https://openalex.org/C2780140890","wikidata":"https://www.wikidata.org/wiki/Q1129338","display_name":"Granuloma","level":2,"score":0.4789745807647705},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4568013846874237},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13509777188301086},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09631532430648804},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002493","descriptor_name":"Central Nervous System Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006331","descriptor_name":"Heart Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007239","descriptor_name":"Infections","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012507","descriptor_name":"Sarcoidosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012507","descriptor_name":"Sarcoidosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012507","descriptor_name":"Sarcoidosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:26120779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26120779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental rheumatology","raw_type":"Journal Article"},{"id":"mag:2423966313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26120779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220874555","https://openalex.org/W4392819019","https://openalex.org/W6990615864","https://openalex.org/W4399483754","https://openalex.org/W2025024872","https://openalex.org/W4387970544","https://openalex.org/W2591931659","https://openalex.org/W2261504070","https://openalex.org/W2154811627","https://openalex.org/W2045831110"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Infliximab":[1],"(IFX)":[2],"appears":[3],"to":[4,157,204,237],"be":[5],"effective":[6],"in":[7,17,74,131,177,213,225],"refractory":[8,216],"sarcoidosis.":[9,217],"However,":[10],"data":[11],"are":[12],"lacking":[13],"regarding":[14],"its":[15],"efficacy":[16],"severe":[18,214],"sarcoidosis":[19],"(i.e.":[20],"with":[21,35,78,182,228],"cardiac":[22,125],"and/or":[23],"neurological":[24],"involvement).":[25],"METHODS:":[26],"Retrospective":[27],"single-centre":[28],"study":[29],"including":[30],"16":[31],"unselected":[32],"consecutive":[33],"patients":[34,145,227],"biopsy":[36],"proven,":[37],"severe,":[38],"and":[39,55,64,94,109,126,136,169,193,215,222,233],"resistant":[40],"sarcoidosis,":[41],"who":[42],"were":[43,174,220],"treated":[44],"by":[45],"infliximab":[46],"(3":[47],"or":[48],"5":[49],"mg":[50],"/kg":[51],"at":[52],"0,":[53],"2":[54,91],"6":[56,88],"weeks,":[57],"then":[58],"every":[59],"8":[60],"weeks)":[61],"between":[62,107],"2005":[63],"2013.":[65],"RESULTS:":[66],"Following":[67],"IFX":[68,197,210],"therapy":[69],"we":[70,120,159],"observed":[71,121,160,176],"an":[72],"improvement":[73],"92%":[75],"of":[76,82,112,124,134,144,153,186,231],"cases,":[77,140],"a":[79,122,147,150,183],"marked":[80],"decrease":[81],"the":[83,110,116],"severity":[84],"score":[85,87],"[median":[86],"(3-12)":[89],"vs.":[90,102,189,199],"(1-8),":[92],"p<0.0001]":[93],"trend":[95],"toward":[96],"steroid":[97],"sparing":[98],"effect":[99],"[12.5":[100],"(0-40)":[101],"8.5":[103],"mg/d":[104],"(0-30),":[105],"p=0.11]":[106],"baseline":[108],"end":[111],"follow-up,":[113],"respectively.":[114,141,208],"Regarding":[115],"index":[117],"organ":[118],"response,":[119],"remission":[123],"central":[127],"nervous":[128],"system":[129],"involvements":[130],"4":[132,135],"out":[133,138],"11":[137],"12":[139],"Thirty-eight":[142],"percent":[143],"experienced":[146],"relapse.":[148],"After":[149],"median":[151],"follow-up":[152],"57":[154],"months":[155],"(2":[156],"91),":[158],"7":[161],"(44%)":[162],"infectious":[163],"complications,":[164],"1":[165,170],"paradoxical":[166],"cutaneous":[167],"granuloma":[168],"leucoencephalopathy.":[171],"Infectious":[172,218],"complications":[173,219],"mostly":[175],"male":[178,226],"[6/7":[179],"(86%),":[180],"p=0.06],":[181],"longer":[184,229],"duration":[185,230],"steroids":[187,232],"(108":[188],"39":[190],"months,":[191,201],"p=0.11)":[192],"immunosuppressant":[194,234],"use":[195,235],"prior":[196,236],"(42":[198],"24":[200],"p=0.08)":[202],"compared":[203],"their":[205],"negative":[206],"counterpart,":[207],"CONCLUSIONS:":[209],"was":[211],"efficient":[212],"frequent":[221],"occurred":[223],"mainly":[224],"IFX.":[238]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}